Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAVITOCLAX: 173 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
173
Total FAERS Reports
48 (27.7%)
Deaths Reported
119
Hospitalizations
173
As Primary/Secondary Suspect
39
Life-Threatening
2
Disabilities

First Report: 201101 · Latest Report: 20241115

What Are the Most Common NAVITOCLAX Side Effects?

#1 Most Reported
Sepsis
25 reports (14.5%)
#2 Most Reported
Pneumonia
24 reports (13.9%)
#3 Most Reported
Thrombocytopenia
21 reports (12.1%)

All NAVITOCLAX Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Sepsis 25 14.5% 10 22
Pneumonia 24 13.9% 5 23
Thrombocytopenia 21 12.1% 8 12
Febrile neutropenia 17 9.8% 2 16
Pyrexia 16 9.3% 2 15
Fatigue 14 8.1% 2 10
Anaemia 13 7.5% 1 11
Diarrhoea 13 7.5% 2 11
Acute kidney injury 12 6.9% 5 11
Off label use 11 6.4% 10 1
Urinary tract infection 10 5.8% 1 10
Death 9 5.2% 9 3
Multiple organ dysfunction syndrome 9 5.2% 9 6
Dehydration 8 4.6% 2 6
Disease progression 8 4.6% 6 3
Platelet count decreased 8 4.6% 2 6
Vomiting 8 4.6% 2 7
Asthenia 7 4.1% 1 6
Dyspnoea 7 4.1% 1 6
Hypoxia 7 4.1% 0 7

Who Reports NAVITOCLAX Side Effects? Age & Gender Data

Gender: 35.0% female, 65.0% male. Average age: 40.5 years. Most reports from: US. View detailed demographics →

Is NAVITOCLAX Getting Safer? Reports by Year

YearReportsDeathsHosp.
2011 1 1 0
2015 3 2 0
2016 2 1 2
2017 4 0 1
2018 19 7 15
2019 30 4 28
2020 23 2 21
2021 27 10 19
2022 18 4 17
2023 14 4 11
2024 4 2 3

View full timeline →

What Is NAVITOCLAX Used For?

IndicationReports
Myelofibrosis 58
Acute lymphocytic leukaemia 30
Acute lymphocytic leukaemia recurrent 18
Neoplasm 14
Product used for unknown indication 9
Acute myeloid leukaemia 5
Malignant melanoma 5
T-cell type acute leukaemia 5

NAVITOCLAX vs Alternatives: Which Is Safer?

NAVITOCLAX vs NAXITAMAB-GQGK NAVITOCLAX vs NEBIVOLOL NAVITOCLAX vs NECITUMUMAB NAVITOCLAX vs NEDAPLATIN NAVITOCLAX vs NEFAZODONE NAVITOCLAX vs NEFOPAM NAVITOCLAX vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG NAVITOCLAX vs NELARABINE NAVITOCLAX vs NELFINAVIR NAVITOCLAX vs NELVUTAMIG

Official FDA Label for NAVITOCLAX

Official prescribing information from the FDA-approved drug label.